Episode Details
Back to Episodes
Chip Scale Laser Fuels Portable Quantum, Vutrisiran Promises in ATTR CM, New ReNU2 Syndrome Reveals Severity, Fluvoxamine Reduces Long COVID Fatigue, and more...
Published 2 weeks, 2 days ago
Description
(0:10): Breakthrough in Compact Quantum Computing: Chip-Scale Laser Drives Portable Quantum Devices
(2:20): Alnylam's Vutrisiran Shows Promising Results in ATTR-CM; Robust Real-World Adherence Reported
(4:44): Newly Identified ReNU2 Syndrome Sheds Light on Severe Childhood Epilepsy and Neurodevelopmental Disorders
(7:16): Fluvoxamine Shows Promise in Reducing Long COVID Fatigue, Study Reveals
(9:20): Study Warns Vaping May Trigger DNA Changes, Cancer Risks; Calls for Stricter Regulations
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Stock Titan
(2:20): Alnylam's Vutrisiran Shows Promising Results in ATTR-CM; Robust Real-World Adherence Reported
(4:44): Newly Identified ReNU2 Syndrome Sheds Light on Severe Childhood Epilepsy and Neurodevelopmental Disorders
(7:16): Fluvoxamine Shows Promise in Reducing Long COVID Fatigue, Study Reveals
(9:20): Study Warns Vaping May Trigger DNA Changes, Cancer Risks; Calls for Stricter Regulations
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Stock Titan